GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span

Endocrinology

Volumn 154, Issue 10, 2013, Pages 3702-3718

  Gillespie, J R ^a,b   Bush, J R ^a,b   Bell, G I ^a,c   Aubrey, L A ^a,b   Dupuis, H ^a,b   Ferron, M ^d,h   Kream, B ^e   DiMattia, G ^f   Patel, S ^g   Woodgett, J R ^g   Karsenty, G ^d   Hess, D A ^a,c   Beier, Frank ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^f LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

^h CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE DEVELOPMENT; BONE GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GLUCOSE BLOOD LEVEL; INSULIN SENSITIVITY; LIFESPAN; MALE; METABOLISM; MOUSE; NONHUMAN; OSTEOBLAST; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKELETON;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; COLLAGEN TYPE I; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; ENERGY METABOLISM; FEMALE; GLYCOGEN SYNTHASE KINASE 3; INSULIN RESISTANCE; MALE; MALE UROGENITAL DISEASES; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; UROGENITAL SYSTEM; WEANING;

EID: 84884687398     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1155     Document Type: Article

References (68)

1. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol. 2008;40:46-62. (Pubitemid 350052658)
2. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol. 2000;16:191-220. (Pubitemid 32037505)
3. Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332-336. (Pubitemid 40852707)
4. Provot S, Schipani E. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun. 2005;328:658-665. (Pubitemid 40208303)
5. Beier F. Cell-cycle control and the cartilage growth plate. J Cell Physiol. 2005;202:1-8. (Pubitemid 39603357)
6. Kobayashi T, Kronenberg H. Minireview: transcriptional regulation in development of bone. Endocrinology. 2005;146:1012-1017. (Pubitemid 40289289)
7. Kronenberg HM. The role of the perichondrium in fetal bone development. Ann NY Acad Sci. 2007;1116:59-64. (Pubitemid 350274341)
8. Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans. 2004;32:803-808. (Pubitemid 39524384)
9. Woodgett JR. Judging a protein by more than its name: GSK-3. Sci STKE. 2001;2001:RE12.
10. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci. 2003;116:1175-1186. (Pubitemid 36410657)
11. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-789. (Pubitemid 26004411)
12. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell. 2007;12:957-971. (Pubitemid 46805920)
13. Liu S, Fang X, Hall H, et al. Homozygous deletion of glycogen synthase kinase 3β bypasses senescence allowing Ras transformation of primary murine fibroblasts. Proc Natl Acad Sci USA. 2008;105:5248-5253. (Pubitemid 351738542)
14. Liang MH, Chuang DM. Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem. 2006;281:30479-30484.
15. Kerkela R, Kockeritz L, Macaulay K, et al. Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest. 2008;118:3609-3618.
16. McManus EJ, Sakamoto K, Armit LJ, et al. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. Embo J. 2005;24:1571-1583. (Pubitemid 40646447)
17. Ciaraldi TP, Oh DK, Christiansen L, et al. Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab. 2006;291:E891-898.
18. Patel S, Doble BW, Macaulay K, Sinclair EM, Drucker DJ, Woodgett JR. Tissue-specific role of glycogen synthase kinase-3β in glucose homeostasis and insulin action. Mol Cell Biol. 2008;28:6314-6328.
19. Patel S, Macaulay K, Woodgett JR. Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain Variation. PLoS One. 2011;6:e15845.
20. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature. 2000;406:86-90. (Pubitemid 30460216)
21. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT. Chemical rescue of cleft palate and midline defects in conditional GSK-3β mice. Nature. 2007;446:79-82. (Pubitemid 46348041)
22. Kugimiya F, Kawaguchi H, Ohba S, et al. GSK-3β controls osteogenesis through regulating Runx2 activity. PLoS ONE. 2007;2:e837.
23. Gillespie JR, Ulici V, Dupuis H, et al. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression. Endocrinology. 2011;152:1755-1766.
24. Tanabe K, Liu Z, Patel S, et al. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol. 2008;6:e37.
25. Cochrane RL, Clark SH, Harris A, Kream BE. Rearrangement of a conditional allele regardless of inheritance of a Cre recombinase transgene. Genesis. 2007;45:17-20. (Pubitemid 46214287)
26. Liu F, Woitge HW, Braut A, Kronenberg MS, Lichtler AC, Mina M, Kream BE. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol. 2004;48:645-653. (Pubitemid 39506707)
27. Wang G, Woods A, Agoston H, Ulici V, Glogauer M, Beier F. Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev Biol. 2007;306:612-623. (Pubitemid 46873537)
28. Ulici V, Hoenselaar KD, Agoston H, et al. The role of Akt1 in terminal stages of endochondral bone formation: Angiogenesis and ossification. Bone. 2009;45:1133-1145.
29. Solomon LA, Li JR, Berube NG, Beier F. Loss of ATRX in chondrocytes has minimal effects on skeletal development. PLoS One. 2009;4:e7106.
30. Yan Q, Feng Q, Beier F. Endothelial nitric oxide synthase deficiency in mice results in reduced chondrocyte proliferation and endochondral bone growth. Arthritis Rheum. 2010;62:2013-2022.
31. Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F. p38 MAPkinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J. 2004;378:53-62. (Pubitemid 38299543)
32. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296-308.
33. Blitz E, Viukov S, Sharir A, et al. Bone ridge patterning during musculoskeletal assembly is mediated through SCX regulation of Bmp4 at the tendon-skeleton junction. Developmental cell. 2009;17:861-873.
34. Holmen SL, Zylstra CR, Mukherjee A, et al. Essential role of betacatenin in postnatal bone acquisition. J Biol Chem. 2005;280:21162-21168. (Pubitemid 40805677)
35. Chen M, Zhu M, Awad H, et al. Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci. 2008;121:1455-1465. (Pubitemid 351936310)
36. Chen Y, Whetstone HC, Youn A, et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem. 2007;282:526-533. (Pubitemid 47076655)
37. Baron R, Rawadi G. Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007;148:2635-2643. (Pubitemid 46984775)
38. Tamamura Y, Otani T, Kanatani N, et al. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem. 2005;280:19185-19195. (Pubitemid 41379625)
39. Akiyama H, Lyons JP, Mori-Akiyama Y, et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev. 2004;18:1072-1087. (Pubitemid 38620246)
40. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16:2813-2828. (Pubitemid 35253149)
41. Song JH, Kim JH, Park S, et al. Signaling responses of osteoblast cells to hydroxyapatite: the activation of ERK and SOX9. J Bone Miner Metab. 2008;26:138-142. (Pubitemid 351317130)
42. Komori T. Regulation of bone development and maintenance by Runx2. Front Biosci. 2008;13:898-903. (Pubitemid 351594735)
43. Hooper ACB. Effects of divergent selection for body-weight on bone length and diameter in mice. Anim Prod. 1977;24:77-82.
44. Hooper ACB. Further Study of Effects of Selection for Relative Bone Length. J Anat. 1977;124:495-496.
45. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009;20:230-236.
46. Yoshizawa T, Hinoi E, Jung DY, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest. 2009;119:2807-2817.
47. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469. (Pubitemid 47208519)
48. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309-319.
49. Scheller EL, Leinninger GM, Hankenson KD, Myers MG, Jr., Krebsbach PH. Ectopic expression of Col2.3 and Col3.6 promoters in the brain and association with leptin signaling. Cells Tissues Organs. 2011;194:268-273.
50. Inoue T, Kido Y, Asahara S, et al. Effect of intrauterine undernutrition during late gestation on pancreatic β cell mass. Biomed Res. 2009;30:325-330.
51. Cox AR, Gottheil SK, Arany EJ, Hill DJ. The effects of low protein during gestation on mouse pancreatic development and β cell regeneration. Pediatr Res. 2010;68:16-22.
52. Carneiro FS, Giachini FR, Lima VV, et al. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med. 2008;5:1156-1166. (Pubitemid 351618021)
53. Jin HR, Kim WJ, Song JS, et al. Functional and morphologic characterizations of the diabetic mouse corpus cavernosum: comparison of a multiple low-dose and a single high-dose streptozotocin protocols. J Sex Med. 2009;6:3289-3304.
54. Toque HA, da Silva FH, Calixto MC, et al. High-fat diet associated with obesity induces impairment of mouse corpus cavernosum responses. BJU Int. 2011;107:1628-1634.
55. Bakris GL. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2011;86:444-456.
56. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004;65:116-128. (Pubitemid 38037496)
57. Kawasaki Y, Kugimiya F, Chikuda H, et al. Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J Clin Invest. 2008;118:2506-2515. (Pubitemid 351949778)
58. Hinoi E, Bialek P, Chen YT, et al. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev. 2006;20:2937-2942. (Pubitemid 44771727)
59. Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR, Snider WD. GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci. 2009;12:1390-1397.
60. Hussain K, Challis B, Rocha N, et al. An activating mutation of AKT2 and human hypoglycemia. Science. 2011;334:474.
61. Chamson-Reig A, Thyssen SM, Arany E, Hill DJ. Altered pancreatic morphology in the offspring of pregnant rats given reduced dietary protein is time and gender specific. J Endocrinol. 2006;191:83-92. (Pubitemid 44756510)
62. Chamson-Reig A, Thyssen SM, Hill DJ, Arany E. Exposure of the pregnant rat to low protein diet causes impaired glucose homeostasis in the young adult offspring by different mechanisms in males and females. Exp Biol Med (Maywood). 2009;234:1425-1436.
63. Vadhavkar M, Golbidi S, Sea J, Longpre M, Stothers L, Laher I. Exercise improves bladder function in diabetic mice. Neurourol Urodyn. 2011;30:174-182.
64. Castro JC, Camargos AF, Goulart EA, Junqueira HS. Sonographic evaluation of bladder volume in diabetic children and adolescents compared with nondiabetic subjects. J Ultrasound Med. 2004;23:1307-1313. (Pubitemid 39304957)
65. Tesch GH, Lim AK. Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2011;300:F301-310.
66. Baynes J, Murray DB. Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats. Oxid Med Cell Longev. 2009;2:328-334.
67. Toyota N, Ogawa D, Ishii K, et al. Emphysematous cystitis in a patient with type 2 diabetes mellitus. Acta Med Okayama. 2011;65:129-133.
68. Jafar TH, Schmid CH, Stark PC, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant. 2003;18:2047-2053.